AKT1 and breast carcinoma: Dey-Guha et al. found that TTC3-mediated proteasome-dependent degradation was involved in the β1 integrin/FAK/mTORC2/AKT1-related signalling pathway, thereby mediating the chemo-resistance of breast cancer cells [38].